www.fdanews.com/articles/192706-fda-grants-breakthrough-status-on-checkpoints-electrostimulation-therapy-system
![FDA_Logo_Black_2016.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA_Logo_Black_2016.gif?t=1579040596&width=430)
FDA Grants Breakthrough Status on Checkpoint’s Electrostimulation Therapy System
September 12, 2019
Checkpoint Surgical has earned the FDA’s breakthrough designation for its brief electrostimulation therapy system (BEST), a device designed to treat nerve injuries.
The device is intended to be used in combination with surgical intervention following nerve injury to speed up patient recovery.
BEST uses low-level electrical currents to stimulate a patient’s peripheral nerves and encourage nerve regeneration.